ENDRA Life Sciences (NDRA)
(Delayed Data from NSDQ)
$0.21 USD
-0.02 (-7.37%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $0.22 +0.01 (4.12%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
NDRA 0.21 -0.02(-7.37%)
Will NDRA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NDRA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NDRA
Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher
NDRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NDRA
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements
Endra Life Sciences granted extension to regain Nasdaq compliance
ENDRA Life Sciences Inc (NDRA) Q2 2024 Earnings Call Transcript Highlights: Strategic Shifts ...
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update